Prospective, randomized, controlled, multicenter pilot study investigating the therapy of increased blood pressure with help of a digital program
- Conditions
- I10I11I12I13Essential (primary) hypertensionHypertensive heart diseaseHypertensive renal diseaseHypertensive heart and renal disease
- Registration Number
- DRKS00031923
- Lead Sponsor
- Vantis GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 115
patients with increased blood pressure
- patient understands the patient information and gives written consent for study participation
- no compatible smartphone available or lacking knowledge of smartphone usage
- insufficient understanding of the offered language (German)
- start of study participation in another clinical study after inclusion in the present study
- participation in a lifestyle-related rehabilitation, or device-based blood pressure therapy, or such a rehabilitation/therapy has been conducted in the last 2 months
- critical or unstable health status
- dependency or employment relation to the sponsor or investigator
- prior usage of a comparable digital therapy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method - decrease of systolic blood pressure after 13 weeks in practice measurement
- Secondary Outcome Measures
Name Time Method - decrease of diastolic blood pressure (BP) for patients with diastolic BP >84mmHg at inclusion<br>- change of resting state heart rate for patients with heart rate >50 at inclusion<br>- change of body mass index (BMI) for patients with BMI > 25<br>- number of patients in target range after 13 weeks<br>- improvement of therapy adherence, measured with the questionnaire Selbstfürsorge des Bluthochdrucks<br>- increase of patient proportion with blood pressure protocol (blood pressure regularly measured and protocoled with a diary at minimum 8 of the last 14 days)<br>- number of unplanned physician visits for cardiovascular complaints